Jonathan Jay Mazelsky - 20 May 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
20 May 2022
Net transactions value
+$99,970
Form type
4
Filing time
23 May 2022, 17:00:49 UTC
Previous filing
07 Mar 2022
Next filing
08 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99,970 +706 +1.4% $141.60 51,301 20 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -706 -100% 0 20 May 2022 Common Stock 706 $141.60 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 9 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2022.
F2 Grant of option to buy 706 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on February 14, 2022.
F3 Not applicable.